Effect and Safety of Rosuvastatin in Acute Ischemic Stroke
Ji Hoe Heo, Dongbeom Song, Hyo Suk Nam, Eung Yeop Kim, Young Dae Kim, Kyung-Yul Lee, Ki-Jeong Lee, Joonsang Yoo, Youn Nam Kim, Byung Chul Lee, Byung-Woo Yoon, Jong S. Kim, EUREKA Investigators
J Stroke. 2016;18(1):87-95.   Published online 2016 Jan 29     DOI: https://doi.org/10.5853/jos.2015.01578
Citations to this article as recorded by Crossref logo
Statins and the risk of bleeding in patients taking dabigatran
Bo‐Lin Ho, Ya‐Ju Lin, Sheng‐Feng Lin, Ping‐Song Chou, Chien‐Fu Chen, Ruey‐Tay Lin, Han‐Hwa Hu, A‐Ching Chao
Acta Neurologica Scandinavica.2019; 139(5): 455.     CrossRef
Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
Irene Tramacere, Giorgio B. Boncoraglio, Rita Banzi, Cinzia Del Giovane, Koren H. Kwag, Alessandro Squizzato, Lorenzo Moja
BMC Medicine.2019;[Epub]     CrossRef
Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms
Yunes Panahi, Yasin Ahmadi, Manouchehr Teymouri, Thomas P. Johnston, Amirhossein Sahebkar
Journal of Cellular Physiology.2018; 233(1): 141.     CrossRef
The Synergistic Neuroprotective Effects of Combined Rosuvastatin and Resveratrol Pretreatment against Cerebral Ischemia/Reperfusion Injury
Ying Liu, HongNa Yang, GuoYong Jia, Lan Li, Hui Chen, JianZhong Bi, CuiLan Wang
Journal of Stroke and Cerebrovascular Diseases.2018; 27(6): 1697.     CrossRef
Silent brain infarction: a quiet predictor of future stroke
Oh Young Bang
Precision and Future Medicine.2018; 2(4): 167.     CrossRef
Rosuvastatin prevents aortic arch plaque progression and improves prognosis in ischemic stroke patients
Kazuyoshi Kaneko, Hiroki Saito, Toshiki Sasaki, Shigeo Sugawara, Masahiro Akasaka, Tohru Kanaya, Isao Kubota
Neurological Research.2017; 39(2): 133.     CrossRef
The efficacy and safety of high-dose statins in acute phase of ischemic stroke and transient ischemic attack: a systematic review
Jing-xue Fang, Er-qiang Wang, Wei Wang, Yang Liu, Gang Cheng
Internal and Emergency Medicine.2017; 12(5): 679.     CrossRef
The Efficacy and Safety of 3 Types of Interventions for Stroke Prevention in Patients With Cardiovascular and Cerebrovascular Diseases: A Network Meta-analysis
Qian Sun, Shumei Chang, Songtao Lu, Yajing Zhang, Yajun Chang
Clinical Therapeutics.2017; 39(7): 1291.     CrossRef
Effects of Statin Intensity and Adherence on the Long-Term Prognosis After Acute Ischemic Stroke
Jinkwon Kim, Hye Sun Lee, Chung Mo Nam, Ji Hoe Heo
Stroke.2017; 48(10): 2723.     CrossRef
Statin Pretreatment and Microembolic Signals in Large Artery Atherosclerosis
Apostolos Safouris, Christos Krogias, Vijay K. Sharma, Aristeidis H. Katsanos, Simon Faissner, Andromachi Roussopoulou, Christina Zompola, Janina Kneiphof, Odysseas Kargiotis, Spyridon Deftereos, Georgios Giannopoulos, Nikos Triantafyllou, Konstantinos Vo
Arteriosclerosis, Thrombosis, and Vascular Biology.2017; 37(7): 1415.     CrossRef
Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke
Aldo Bonaventura, Luca Liberale, Alessandra Vecchié, Matteo Casula, Federico Carbone, Franco Dallegri, Fabrizio Montecucco
International Journal of Molecular Sciences.2016; 17(12): 1967.     CrossRef
Statin Intensity and Clinical Outcome in Patients with Stable Coronary Artery Disease and Very Low LDL-Cholesterol
Soo Youn Lee, Seung-Jin Oh, Eung Ju Kim, Chi-Yoon Oum, Sung Hwan Park, Jaewon Oh, Jung-Sun Kim, Byeong-Keuk Kim, Sungha Park, Hyuk-Jae Chang, Geu-Ru Hong, Young-Guk Ko, Seok-Min Kang, Donghoon Choi, Jong-Won Ha, Myeong-Ki Hong, Yangsoo Jang, Namsik Chung,
PLOS ONE.2016; 11(11): e0166246.     CrossRef